Amylyx Pharmaceuticals' ALS drug, Relyvrio, has failed in a Phase III trial, showing no efficacy... (12 revisions)
Napo Pharmaceuticals, a Jaguar Health Family Company, will exhibit at the Oncology Nursing... (14 revisions)
